Litcius/Paper detail

Biomimetic nanoplatform with anti-inflammation and neuroprotective effects for repairing spinal cord injury in mice

Xuechen Yin, Sen Lin, Ying Xiong, Peng Zhang, Xifan Mei

2023Materials Today Bio12 citationsDOIOpen Access PDF

Abstract

Regeneration in the therapeutics of spinal cord injury (SCI) remains a challenge caused by the hyperinflammation microenvironment. Nanomaterials-based treatment strategies for diseases with excellent therapeutic efficacy are actively pursued. Here, we develop biodegradable poly (lactic-co-glycolic acid) nanoparticles (PLGA) obtained by loading celastrol (pCel) for SCI thrapy. Cel, as an antioxidant drug, facilitated reactive oxygen species (ROS) scavenging, and decreased the generation of pro-inflammatory cytokines. To facilitate its administration, pCel is formulated into microspheres by oil-in-water (O/W) emulsion/solvent evaporation technique. The constructed pCel can induced polarization of macrophages and obviously improved lipopolysaccharide (LPS) and interferon-γ (IFN-γ)-induced mitochondrial dysfunction, and increased neurite length in PC12 cells and primary neurons. In vivo experiments revealed that pCel regulated the phenotypic polarization of macrophages, prevented the release of pro-inflammatory cytokines, promoted myelin regeneration and inhibited scar tissue formation, and further improve motor function. These findings indicated that the neuroprotective effect of this artificial biodegradable nanoplatform is benefit for the therapy of SCI. This research opens an exciting perspective for the application of SCI treatment and supports the clinical significance of pCel.

Topics & Concepts

NeuroprotectionSpinal cord injuryPharmacologyInflammationPLGAReactive oxygen speciesLipopolysaccharideNeuroinflammationNeuroregenerationNeuriteChemistryIn vivoSpinal cordMedicineImmunologyBiochemistryIn vitroBiologyPsychiatryBiotechnologySpinal Cord Injury ResearchNatural Compounds in Disease TreatmentBone and Joint Diseases